Cargando…

Insights and advances in recurrent vulvovaginal candidiasis

Detalles Bibliográficos
Autores principales:	San Juan Galán, Javier, Poliquin, Vanessa, Gerstein, Aleeza Cara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Pearls
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637712/ https://www.ncbi.nlm.nih.gov/pubmed/37948448 http://dx.doi.org/10.1371/journal.ppat.1011684

Ejemplares similares

Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis
por: Ge, Gai, et al.
Publicado: (2022)

Recurrent Vulvovaginal Candidiasis: An Immunological Perspective
por: Rosati, Diletta, et al.
Publicado: (2020)

Treatment of Recurrent Vulvovaginal Candidiasis With Ibrexafungerp
por: Grant, Leah M., et al.
Publicado: (2022)

Candida and Host Determinants of Susceptibility to Invasive Candidiasis
por: Lionakis, Michail S., et al.
Publicado: (2013)

Oropharyngeal Candidiasis: Fungal Invasion and Epithelial Cell Responses
por: Swidergall, Marc, et al.
Publicado: (2017)

Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment
por: Woodburn, Kathryn W., et al.
Publicado: (2019)

Topical Treatment of Recurrent Vulvovaginal Candidiasis: An Expert Consensus
por: Phillips, Nancy A., et al.
Publicado: (2022)

Clinical challenges in diagnosis and treatment of recurrent vulvovaginal candidiasis
por: Neal, Chemen M, et al.
Publicado: (2022)

Candidiasis vulvovaginal: revisión bibliográfica.
por: Caballero Salmeron, María Esther
Publicado: (1995)

New Treatments for Vulvovaginal Candidiasis
por: Faro, Sebastian
Publicado: (1996)

Changing Trends of Vulvovaginal Candidiasis
por: Vijaya, Doddaiah, et al.
Publicado: (2014)

Clinicomycological study of vulvovaginal candidiasis
por: Seeniammal, S., et al.
Publicado: (2021)

The Recurrent Vulvovaginal Candidiasis: Proposal of a Personalized Therapeutic Protocol
por: Murina, F., et al.
Publicado: (2011)

Practices of Lebanese gynecologists regarding treatment of recurrent vulvovaginal candidiasis
por: Adib, Salim M., et al.
Publicado: (2011)

Clinical and morphopathological assay in vulvovaginal candidiasis
por: Manolea, Maria Magdalena, et al.
Publicado: (2022)

A Complex Microbial Interplay Underlies Recurrent Vulvovaginal Candidiasis Pathobiology
por: Papon, Nicolas, et al.
Publicado: (2021)

Non-enveloped virus membrane penetration: New advances leading to new insights
por: Pletan, Madison L., et al.
Publicado: (2022)

Highly-cited estimates of the cumulative incidence and recurrence of vulvovaginal candidiasis are inadequately documented
por: Rathod, Sujit D, et al.
Publicado: (2014)

Gene polymorphisms in pattern recognition receptors and susceptibility to idiopathic recurrent vulvovaginal candidiasis
por: Rosentul, Diana C., et al.
Publicado: (2014)

Recurrent Vulvovaginal Candidiasis: a Dynamic Interkingdom Biofilm Disease of Candida and Lactobacillus
por: McKloud, Emily, et al.
Publicado: (2021)

Treating (Recurrent) Vulvovaginal Candidiasis with Medical-Grade Honey—Concepts and Practical Considerations
por: van Riel, Senna J. J. M., et al.
Publicado: (2021)

Compliance with the Updated BASHH Recurrent Vulvovaginal Candidiasis Guidelines Improves Patient Outcomes
por: Brown, Lottie, et al.
Publicado: (2022)

Candidiasis vulvovaginal tratamiento oral con itraconazol/
por: Rodriguez Serrano, Tiburcio Manuel
Publicado: (1993)

Lamisil versus clotrimazole in the treatment of vulvovaginal candidiasis
por: Mahmoudabadi, Ali Zarei, et al.
Publicado: (2013)

Sexual function, depression, anxiety, and vulvovaginal candidiasis
por: Başer, Emre, et al.
Publicado: (2021)

Mannose-Binding Lectin Gene Polymorphism and Its Association with Susceptibility to Recurrent Vulvovaginal Candidiasis
por: Hammad, Noha M., et al.
Publicado: (2018)

Antifungal (oral and vaginal) therapy for recurrent vulvovaginal candidiasis: a systematic review protocol
por: Lírio, Juliana, et al.
Publicado: (2019)

An Exaggerated Monocyte-Derived Cytokine Response to Candida Hyphae in Patients With Recurrent Vulvovaginal Candidiasis
por: Rosati, Diletta, et al.
Publicado: (2020)

Vulvovaginal Candidiasis in Pregnancy—Between Sensitivity and Resistance to Antimycotics
por: Maftei, Nicoleta-Maricica, et al.
Publicado: (2023)

Systemic vs. Topical Therapy for the Treatment of Vulvovaginal Candidiasis
por: Faro, Sebastian
Publicado: (1994)

Vulvovaginal Candidiasis: A Current Understanding and Burning Questions
por: Willems, Hubertine M. E., et al.
Publicado: (2020)

Pathogenesis and Clinical Relevance of Candida Biofilms in Vulvovaginal Candidiasis
por: Rodríguez-Cerdeira, Carmen, et al.
Publicado: (2020)

Peroxisomes in host defense
por: Di Cara, Francesca
Publicado: (2020)

Pathogenesis insights from an ancient and ubiquitous spirochete
por: Coburn, Jenifer, et al.
Publicado: (2021)

Insights into potential causes of vascular hyperpermeability in dengue
por: Teo, Andrew, et al.
Publicado: (2021)

Candida causes recurrent vulvovaginal candidiasis by forming morphologically disparate biofilms on the human vaginal epithelium
por: Pan, Yihong, et al.
Publicado: (2023)

“Efficacy and safety of oteseconazole in recurrent vulvovaginal candidiasis (RVVC) – A systematic review and meta-analysis"
por: Siddiqui, Tasmiyah, et al.
Publicado: (2023)

Recurrent Vulvovaginal Candidiasis: Could It Be Related to Cell-Mediated Immunity Defect in Response to Candida Antigen?
por: Talaei, Zahra, et al.
Publicado: (2017)

Candida duobushaemulonii: an emerging rare pathogenic yeast isolated from recurrent vulvovaginal candidiasis in Brazil
por: Boatto, Humberto Fabio, et al.
Publicado: (2016)

Correction: Antifungal (oral and vaginal) therapy for recurrent vulvovaginal candidiasis: a systematic review protocol
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0geeiqea2af431a3nv38co9hn0